HopeStage
Back to all studies
CompletedNCT00531518

Early support to prevent psychosis in teens and young adults

About this titleRead the official source — NCT00531518
Medication studyAges 12–25United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 12 years to 25 years.

Listed locations
Sacramento and 5 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2007
Recruitment status
Completed
Enrollment listed in the registry
292
Sponsor
MaineHealth
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Behavioural, Drug
Locations
United States
Age range
From 12 Years to 25 Years
Official registry ID
NCT00531518
Official title
Show the full official title

Early Detection and Intervention for the Prevention of Psychosis Project

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Sacramento · Portland · Ann Arbor

3 more locations
  • Albuquerque
  • Glen Oaks
  • Salem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is MaineHealth.

Did this study involve medication?

Yes. The study involved medication, including aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine.

Who was this study for?

Listed age limits: 12 years to 25 years.

Want to explore more studies?

Explore studies